CHI3L1 and obstructive sleep apnea syndrome: A more detailed phenotypic characterization of patients with OSA with assessment of endothelial function and analysis of biomarkers of inflammation including YKL-40 and angiogenic inhibitors within a larger population will be essential for stratifying the individual risks for development of hypertension and adverse cardiovascular outcome.